| | | MIVACURIUM
CAS:106791-40-6
Formula: C58H80N2O14
95%
106791-40-6
2,2'-[(1,8-Dioxo-4-octene-1,8-diyl)bis(oxy-3,1-propanediyl)]bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]isoquinolinium;Isoquinolinium, 2,2'-((1,8-dioxo-4-octene-1,8-diyl)bis(oxy-3,1-propanediyl))bis(1,2,3 MIXTURE OF CYCLOHEXANE-1,2-DICARBOXYLIC ANHYDRIDE, CIS-CYCLOHEXANE-1,2-DICARBOXYLIC ANHYDRIDE, TRANS-CYCLOHEXANE-1,2-DICARBOXYLIC ANHYDRIDE
Formula: C8H10O3
BB068860
trans-Hexahydro-1,3-isobenzofurandione; rel-(3aR,7aR)-Hexahydro-1,3-isobenzofurandione; dl-trans-1,2-Cyclohexanedicarboxylic Anhydride; rel-(3aS,7aS)-Hexahydroisobenzofuran-1,3-dione; trans-1,2-Cyclohexanedicarboxylic Anhydride; trans-Cyclo MK 0434
CAS:134067-56-4
Formula: C25H31NO2
98%
134067-56-4
MK0434; MK-0434; MK 0434; MK-434; MK434; MK 434; (4aR,4bS,6aS,7S,9aS,9bS,11aR)-7-benzoyl-4a,6a-dimethyl-1,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-2H-indeno[5,4-f]quinolin-2-one;(5alpha,17beta)-17-Benzoyl-4-azaandrost-1-en-3-one;17 MK-386
CAS:158493-17-5
Formula: C28H49NO
GëÑ98% by HPLC
158493-17-5
MK 386; MK386; (4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one MK-5172 HYDRATE
CAS:1350462-55-3
Formula: C38H52N6O10S
>98%
1350462-55-3
(33R,35S,91R,92R,5S)-5-(tert-butyl)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphane-35-carboxamide hydrate; MK-5172 INTERMEDIATE
CAS:1206524-84-6
Formula: C30H40N4O7
98% by HPLC
1206524-84-6
e-8-carboxylate; Grazoprevir intermediate; (1aR,5S,8S,10R,22aR)-5-(1,1-Dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quino MK-6913
CAS:1398510-92-3
Formula: C25H27N3O2
GëÑ95%
1398510-92-3
Tetrahydrofluoroene 52; (S)-3-(tert-Butyl)-9a-(2-phenoxyethyl)-8,9,9a,10-tetrahydrofluoreno[1,2-d][1,2,3]triazol-7(3H)-one; Fluoreno[1,2-d]-1,2,3-triazol-7(3H)-one, 3-(1,1-dimethylethyl)-8,9,9a,10-tetrahydro-9a-(2-phenoxyethyl)-, (9aS)-; (9 ML RR-S2 CDA
CAS:1638241-89-0
Formula: C20H24N10O10P2S2
GëÑ95%
1638241-89-0
2',3'-c-di-AM(PS)2(Rp,Rp); Adenosine, [P(R)]-5'-O-[(R)-hydroxymercaptophosphinyl]-P-thioadenylyl-(2'GåÆ5')-, cyclic nucleotide; (R,R)-(2',3')c-diAM(PS)2; (2',3')-Rp,Rp-c-diAMPSS; dithio-(RP, RP)-[cyclic[A(2',5')pA(3',5')p]]; ML RR-S2 CDA (STI ML-SA1
CAS:332382-54-4
Formula: C22H22N2O3
95%
B2693-169420
ML SA1; ML-SA1; 2-[2-oxo-2-(2,2,4-trimethyl-3,4-dihydroquinolin-1(2H)-yl)ethyl]-1H-isoindole-1,3(2H)-dione; 2-(2-oxo-2-(2,2,4-Trimethyl-3,4-dihydroquinolin-1(2H)-yl)ethyl)isoindoline-1,3-dione; 2-[2-Oxo-2-(2,2,4-trimethyl-3,4-dihydro-2H-qui ML753286
CAS:1699720-89-2
Formula: C20H25N3O3
GëÑ99%
1699720-89-2
Pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, 2,3,6,7,12,12a-hexahydro-9-methoxy-3-methyl-6-(2-methylpropyl)-, (3S,6S,12aR)-; (3S,6S,12aR)-6-Isobutyl-9-methoxy-3-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4- MM-589
CAS:2097887-20-0
Formula: C28H44N8O5
GëÑ95%
2097887-20-0
N-{(3R,6S,9S,12R)-6-Ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl}-2-methylpropanamide; Propanamide, N-[(3R,6S,9S,12R)-6-ethyl-9-[3-[[imino(methylamino)methyl]amino] MNIOPETAL A
CAS:158760-98-6
Formula: C27H40O9
BBF-01949
2-(Acetyloxy)decanoic acid, 4-formyl-3,3a,6,6a,7,8,9,10-octahydro-3,10-dihydroxy-7,7-dimethyl-1-oxo-1H-naptho(1,8-c)furan-yl ester MNIOPETAL B
CAS:158760-99-7
Formula: C25H38O8
BBF-01950
2-Hydroxydecanoic acid, 4-formyl-3,3a,6,6a,7,8,9,10-octahydro-3,10-dihydroxy-7,7-dimethyl-1-oxo-1H-naptho(1,8-c)furan-9-yl ester MNIOPETAL C
CAS:158761-00-3
Formula: C23H34O8
BBF-01951
2-Hydroxyoctanoic acid, 4-formyl-3,3a,6,6a,7,8,9,10-octahydro-3,10-dihydroxy-7,7-dimethyl-1-oxo-1H-naptho(1,8-c)furan-9-yl ester MNIOPETAL D
CAS:158761-01-4
Formula: C25H38O8
BBF-01952
2-Hydroxydecanoic acid, 4-formyl-3,3a,6,6a,7,8 ,9,10-octahydro-3,10-dihydroxy-7,7-dimethyl-1-oxo-1H-naptho(1,8-c)furan-10-yl ester MNIOPETAL F
CAS:158761-03-6
Formula: C15H20O5
BBF-01954
1H-Naphtho(1,8a-c)furan-4-carboxaldehyde, 3,3a,6,6a,7,8,9,10-octahydro-3,10-dihydroxy-7,7-dimethyl-1-oxo-, (3S,3aS,6aS,10S,10aR)- MOGROSIDE I A1
CAS:88901-46-6
Formula: C36H62O9
0.98
88901-46-6
Mogroside I A1; 88901-46-6; Mogroside I-A1; DTXSID501317225; HY-N6854; AKOS040733765; MS-30904; CS-0100283; (2S,3R,4S,5S,6R)-2-[(3R,6R)-6-[(3S,8S,9R,10R,11R,13R,14S,17R)-3,11-dihydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decah MOGROSIDE IV
CAS:89590-95-4
Formula: C54H92O24
>98%
B2703-003393
(1S,4R,9+¦,11+¦,24R)-1-{[6-O-(+¦-D-Glucopyranosyl)-+¦-D-glucopyranosyl]oxy}-11,25-dihydroxy-9,10,14-trimethyl-4,9-cyclo-9,10-secocholest-5-en-24-yl 2-O-+¦-L-glucopyranosyl-+¦-D-glucopyranoside; +¦-D-Glucopyranoside, (1R,4R)-4-[(3+¦,9+¦,10+¦,11+¦,17+¦)- MOLLISORIN A
CAS:72704-04-2
Formula: C20H26O5
72704-04-2
[(3aR,4R,6Z,8S,10E,11aR)-8-hydroxy-6,10-dimethyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] (E)-2-methylbut-2-enoate Molnupiravir Dimethyl Dioxol Impurity
CAS:2346620-55-9
Formula: C16H23N3O7
97%
2346620-55-9
Uridine, 2',3'-O-(1-methylethylidene)-, 4-oxime, 5'-(2-methylpropanoate); 2',3'-O-(1-Methylethylidene)uridine 4-Oxime 5'-(2-Methylpropanoate); ((3aR,4R,6R,6aR)-6-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrof MOMETASONE FUROATE EP IMPURITY E
CAS:1370190-33-2
Formula: C32H32Cl2O8
> 95%
B1370-477795
11,17-Difuroate Mometasone Furoate; (11+¦,16+¦)-9,21-Dichloro-11,17-bis[(2-furanylcarbonyl)oxy]-16-methyl-pregna-1,4-diene-3,20-dione; 9,21-Dichloro-16+¦-methyl-3,20-dioxopregna-1,4-diene-11+¦,17-diyl di(furan-2-carboxylate) MOMETASONE FUROATE EP IMPURITY M
CAS:57780-86-6
Formula: C22H29ClO4
57780-86-6
(11+¦,16+¦)-9-Chloro-11,17-dihydroxy-16-methyl-pregna-1,4-diene-3,20-dione; 9-Chloro-11beta,17-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione; Pregna-1,4-diene-3,20-dione, 9-chloro-11,17-dihydroxy-16-methyl-, (11beta,16alpha)- MOMETASONE FUROATE IMPURITY 10
CAS:201601-32-3
Formula: C29H34O7S
201601-32-3
2-((4aS,4bS,5aS,6aS,7R,8R,9aS,9bS)-7-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl 4-methylbenzenesulfonate Mometasone Furoate-[d8]
Formula: C27H22D8Cl2O6
BLP-015381
Mometasone Furoate-d8; (8S,9R,10S,11S,13S,14S,16R,17R)-9-Chloro-17-(2-chloroacetyl-d2)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl-4,6,6-d3 furan-2-carboxylate-d3 MOMETASONE-17, 20-DIFUROATE
Formula: C32H32Cl2O8
> 95%
(E)-2-chloro-1-((8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-((furan-2-carbonyl)oxy)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)vinyl furan-2-carboxylate Momordicin IV
CAS:894412-35-2
Formula: C36H58O9
GëÑ95%
NP7151
19-Norlanosta-5,24-diene-9-carboxaldehyde, 7-(+¦-D-glucopyranosyloxy)-3,23-dihydroxy-, (3+¦,7+¦,9+¦,10+¦,24R)-; (3S,7S,8S,9R,10R,13R,14S,17R)-3-hydroxy-17-((2R,4R)-4-hydroxy-6-methylhept-5-en-2-yl)-4,4,13,14-tetramethyl-7-(((2R,3R,4S,5S,6R)-3,4, MOMORDICOSIDE B
CAS:75799-04-1
Formula: C47H80O19
>98%
75799-04-1
(3b,9b,10a,22S,23R,24R)-22,23,24,25-Tetrahydroxy-9-methyl-19-norlanost-5-en-3-yl O-b-D-glucopyranosyl-(1-6)-O-[b-D-xylopyranosyl-(1-4)]-b-D-glucopyranoside; (3+¦,9+¦,10+¦,22S,23R,24R)-22,23,24,25-Tetrahydroxy-9-methyl-19-norlanost-5-en-3-yl O- MOMORDICOSIDE G
CAS:81371-54-2
Formula: C37H60O8
96%
NP6944
(1R,4S,5S,8R,9R,12S,13S,16S)-8-[(2R,4E)-6-Methoxy-6-methyl-4-hepten-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl +¦-D-allopyranoside MOMORDICOSIDE K
CAS:81348-84-7
Formula: C37H60O9
GëÑ95%
NP7091
19-Norlanosta-5,23-diene-9-carboxaldehyde, 7-(+¦-D-glucopyranosyloxy)-3-hydroxy-25-methoxy-, (3+¦,7+¦,9+¦,10+¦,23E)-; (1S,4R,7S,9+¦,23E)-9-Formyl-1-hydroxy-25-methoxy-10,14-dimethyl-4,9-cyclo-9,10-secocholesta-5,23-dien-7-yl +¦-D-glucopyranoside MOMORDICOSIDE L
CAS:81348-83-6
Formula: C36H58O9
GëÑ95%
NP7092
19-Norlanosta-5,23-diene-9-carboxaldehyde, 7-(+¦-D-glucopyranosyloxy)-3,25-dihydroxy-, (3+¦,7+¦,9+¦,10+¦,23E)-; (1S,4R,7S,9+¦,23E)-9-Formyl-1,25-dihydroxy-10,14-dimethyl-4,9-cyclo-9,10-secocholesta-5,23-dien-7-yl +¦-D-glucopyranoside; (3+¦,7+¦,9+¦,10 Monacolin L Acid Lithium Salt
CAS:1298116-18-3
Formula: C19H30O4-+Li
BB060412
(+¦R,+¦R,1S,2S,6R,8aR)-1,2,6,7,8,8a-Hexahydro-+¦,+¦-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoic Acid Lithium Salt MONACTIN
CAS:7182-54-9
Formula: C41H66O12
>95% by HPLC
BBF-02609
4,13,22,31,37,38,39,40-Octaoxapentacyclo[32.2.1.17,10.116,19.125,28]tetracontane-3,12,21,30-tetrone,5-ethyl-2,11,14,20,23,29,32-heptamethyl-, (1R,2R,5R,7R,10S,11S,14S,16S,19R,20R,23R,25R,28S,29S,32S,34S)-; Akd-1B MONASCORUBRAMIN
CAS:3627-51-8
Formula: C23H27NO4
GëÑ95%
3627-51-8
Furo[3,2-g]isoquinoline-2,9(7H,9aH)-dione, 9a-methyl-3-(1-oxooctyl)-6-(1E)-1-propen-1-yl-, (9aR)-; (9aR)-9a-Methyl-3-(1-oxooctyl)-6-(1E)-1-propen-1-ylfuro[3,2-g]isoquinoline-2,9(7H,9aH)-dione; Furo[3,2-g]isoquinoline-2,9(7H,9aH)-dione, 9a-m MONAZOMYCIN
CAS:11006-31-8
Formula: C72H133NO22
>95% by HPLC
BBF-04274
Takacidin; U-0142; 48-(7-amino-1-methylheptyl)-8,10,16,20,24,26,28,32,36,38,40,42,44,46-tetradecahydroxy-23-(+¦-D-mannopyranosyloxy)-9,15,17,19,21,25,31,33,39,41,47-undecamethyl-oxacyclooctatetraconta-13,17,21,29-tetraen-2-one MONBARBATAIN A
CAS:138711-55-4
Formula: C30H22O6
GëÑ95%
138711-55-4
2,2'-Dimethoxy-1,1'-biphenanthrene-4,4',7,7'-tetrol; [1,1'-Biphenanthrene]-4,4',7,7'-tetrol, 2,2'-dimethoxy- MONENSIN DECYL ESTER
CAS:164066-23-3
Formula: C46H82O11
164066-23-3
decyl (2S,3R,4S)-4-((2S,7S,8R,9S)-2-((2S,2'R,3'S,5R,5'R)-2-ethyl-5'-((2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyltetrahydro-2H-pyran-2-yl)-3'-methyloctahydro-[2,2'-bifuran]-5-yl)-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-y MONIC ACID A
CAS:66262-68-8
Formula: C17H28O7
95%
66262-68-8
(2E)-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiranyl]methyl]-3-methyl-L-talo-non-2-enonic Acid; [2E,8[2S,3S(1S,2S)]]-5,9-anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-m MONO-(3,5,5-TRIMETHYL-1-HEXYL)PHTHALATE-[RING-1,2-13C2,DICARBOXYL-13C2]
CAS:2483735-85-7
Formula: C13[13C]4H24O4
95% by CP; 99% atom 13C
BLP-009463
2-(3,5,5-trimethylhexoxycarbonyl)benzoate-ring-1,2-13C2-dicarboxyl-13C2; 1,2-Benzenedicarboxylic acid, Mono(3,5,5-trimethylhexyl) ester-ring-1,2-13C2-dicarboxyl-13C2 MONO[2-(PERFLUORODECYL)ETHYL] PHOSPHATE CYCLOHEXYLAMINE SALT
Formula: C12H6F21O4P.2C6H13N
GëÑ95%
3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-Heneicosafluoro-1-dodecanol 1-(dihydrogen phosphate) cyclohexylamine salt MONO[2-(PERFLUORODECYL)ETHYL] SULFATE POTASSIUM SALT
CAS:1262446-14-9
Formula: C12H4F21KO4S
BB059005
3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-Heneicosafluoro-1-dodecanol 1-(Hydrogen Sulfate) Potassium Salt; 10:2 FTOH Sulfate Potassium Salt MONOACETONE-L-GLUCOSE
CAS:121701-18-6
Formula: C9H16NO6
121701-18-6
1,2-O-Isopropylidene +¦-L-glucofuranose; (S)-1-((3aS,5S,6R,6aS)-6-Hydroxy-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-ethane-1,2-diol; O1,O2-isopropylidene-+¦-L-glucofuranose; 1,2-O-(1-Methylethylidene)-+¦-L-glucofuranose Monochlorotriazinyl-beta-Cyclodextrin sodium salt
CAS:187820-08-2
95%
B2705-172072
Monochlortriazingl-+¦-Cyclodextrin; beta-Cyclodextrin, 6-chloro-1,4-dihydro-4-oxo-1,3,5-triazin-2-yl ether, sodium salt; +¦-Cyclodextrin, 6-chloro-1,4-dihydro-4-oxo-1,3,5-triazin-2-yl ethers, sodium salts MONOCROTALINE
CAS:315-22-0
Formula: C16H23NO6
>98%
315-22-0
MONOCROTALIN; MONOCROTALINE; CROTALIN; CROTALINE; (13-alpha,14-alpha)-14,19-dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dio; (13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione; (2,3,4-gh)pyrrolizine-2,6(3h)-di MONODOCOSAHEXAENOIN
CAS:140670-40-2
Formula: C25H38O4
BB059029
(4Z,7Z,10Z,13Z,16Z,19Z)-2,3-Dihydroxypropyl docosa-4,7,10,13,16,19-hexaenoate; Docosahexaenoylglycerol MONOHYDROXYISOAFLAVININE
CAS:116865-09-9
Formula: C28H39NO2
GëÑ98%
BBF-04467
24,25-Dehydro-10,11-dihydro-20-hydroxyaflavinine; 1H-Benzo[d]naphthalene-1,5-diol, dodecahydro-8-(1H-indol-3-yl)-4,4a,7-trimethyl-9-(1-methylethenyl)-, (1+¦,4+¦,4a+¦,5+¦,7+¦,7a+¦,8+¦,9+¦,11aR*)-(+)- MONOMETHYL KOLAVATE
CAS:24513-41-5
Formula: C21H32O4
0.98
NP1256
(-)- 5,9-Dimethyl-17,19-dinor-8betaH-labda-3,13-diene-15,18-dioic acid 15-methyl ester; (4aR,5S,6R,8aR)-5-[(3E)-5-Methoxy-3-methyl-5-oxo-3-penten-1-yl]-5 ,6,8a-trimethyl-3,4,4a,5,6,7,8,8a-octahydro-1-naphthalenecarboxyl ic acid MONORDEN C
CAS:544712-80-3
Formula: C18H19ClO6
>98%
BBF-02562
Pochonin A; 2H-Oxireno[e][2]benzoxacyclotetradecin-6,12(3H,7H)-dione, 8-chloro-1a,14,15,15a-tetrahydro-9,11-dihydroxy-14-methyl-, (1aR,14S,15aR)- MONOTROPEIN
CAS:5945-50-6
Formula: C16H22O11
>98%
B1370-124565
(1S,2S,6S,9R)-9-hydroxy-9-(hydroxymethyl)-2-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-oxabicyclo[4.3.0]nona-4,7-diene-5-carboxylic acid; 1+¦-(+¦-D-Glucopyranosyloxy)-1,4a+¦,7,7a+¦-tetrahydro-7+¦-hydroxy-7-(hydroxymethyl MONTELUKAST CYCLIZED ETHER IMPURITY
CAS:168214-67-3
Formula: C29H26ClNO
GëÑ95%
168214-67-3
Montelukast Impurity 39; 2-(3-(1,1-dimethyl-1,3,4,5-tetrahydrobenzo[c]oxepin-3-yl)styryl)-7-chloroquinoline; Quinoline, 7-chloro-2-[2-[3-(1,3,4,5-tetrahydro-1,1-dimethyl-2-benzoxepin-3-yl)phenyl]ethenyl]-; 7-Chloro-2-[2-[3-(1,3,4,5-tetrahyd MOPIDAMOL
CAS:13665-88-8
Formula: C19H31N7O4
GëÑ95%
13665-88-8
Ethanol, 2,2',2'',2'''-[[4-(1-piperidinyl)pyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilo]tetrakis-; Ethanol, 2,2',2'',2'''-[(4-piperidinopyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetra-; 2,6-Bis(diethanolamino)-4-piperidinopyrimido[5,4-d]p MORACIN P
CAS:102841-46-3
Formula: C19H18O5
0.98
NP4654
5-(6-hydroxy-7,7-dimethyl-3a,4,5,6-tetrahydrofuro[3,2-g]chromen-2-yl)benzene-1,3-diol; 5-[(6R)-6,7-Dihydro-6-hydroxy-7,7-dimethyl-5H-furo[3,2-g][1]benzopyran-2-yl]-1,3-benzenediol MORADIOL DIACETATE
CAS:64763-00-4
Formula: C34H54O4
BBF-05513
3beta,28-diacetoxyoleanan-18(19)-ene; 3+¦,28-diacetoxyoleanan-18(19)-ene; Acetic acid (4aS,6aR,6bR,8aR,10S,12aR,12bR,14aS)-10-acetoxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a-octadecahydro-2H-picen-4a-y MORIN
CAS:480-16-0
Formula: C15H10O7
>98%
B2703-092919
TIMTEC-BB SBB008853; MORIN; 3,5,7,2',4'-PENTAHYDROXYFLAVONE; 2',3,4',5,7-PENTAHYDROXYFLAVONE; FUSTIC; CI 75660; CI NO 75660; 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4h-1-benzopyran-4-on MORIN HYDRATE
CAS:654055-01-3
Formula: C15H10O7.xH2O
>98%
B2703-465104
4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-, hydrate (1:x); 2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one hydrate (1:x); 4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-, hydrate; Flavon MORIN MONOHYDRATE
CAS:6202-27-3
Formula: C15H12O8
>98%
6202-27-3
4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-, hydrate (1:1); 4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-, monohydrate; Flavone, 2',3,4',5,7-pentahydroxy-, monohydrate; 2-(2,4-dihydroxyphenyl)-3,5,7-t MORONIC ACID
CAS:6713-27-5
Formula: C30H46O3
98%
NP6250
Moronic acid;6713-27-5;3-Oxoolean-18-en-28-oic acid;(4aS,6aR,6aR,6bR,8aR,12aR,14aS)-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-4,5,6,6a,7,8,8a,11,12,13,14,14a-dodecahydro-3H-picene-4a-carboxylic acid;XW8W7HC4JK;MLS000563430;CHEBI:30815;Moronicaci Morpholine-[2,2,3,3,5,5,6,6-d8] hydrochloride
CAS:1107650-56-5
Formula: C4H2ClD8NO
Chemical purity > 95%, Isotopic enrichment > 98%
1107650-56-5
Morpholine-2,2,3,3,5,5,6,6-d8 HCl; Morpholine-2,2,3,3,5,5,6,6-d8 hydrochloride; Morpholine-d8 Hydrochloride; Morpholine-d8 HCl; octadeuteromorpholine hydrochloride MORPHOLINE-2,2,3,3,5,5,6,6-D8
CAS:342611-02-3
Formula: C4HNOD8
BB022035
2,2,3,3,5,5,6,6-octadeuteriomorpholine; 2,2,3,3,5,5,6,6-octadeuteriomorpholine Morusignin L
CAS:149733-95-9
Formula: C25H26O7
GëÑ95%
149733-95-9
2H,6H-Benzo[1,2-b:5,4-b']dipyran-6-one, 8-(2,4-dihydroxyphenyl)-5-hydroxy-7-(3-hydroxy-3-methylbutyl)-2,2-dimethyl-; 8-(2,4-Dihydroxyphenyl)-5-hydroxy-7-(3-hydroxy-3-methylbutyl)-2,2-dimethyl-2H,6H-pyrano[3,2-g]chromen-6-one |
